FdaApplication
BLA 761367
Identifiers
- fda_app_no: BLA761367
Properties
| Property | Value |
|---|---|
| applicant_name | CSL Behring LLC |
| application_type | BLA |
| approval_date | 2025-06-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANDEMBRY | GARADACIMAB-GXII | 200MG/1.2ML (167MG/ML) | Injection |
| ANDEMBRY | — | 200MG/1.2ML (167MG/ML) | Injection |
2 products